Workflow
LEEJUN(002651)
icon
Search documents
利君股份拟设海外子公司拓展国际市场 2025年业绩预计下滑
Jing Ji Guan Cha Wang· 2026-02-13 08:08
Group 1 - The company plans to establish subsidiaries in Hong Kong and Peru through its Singapore subsidiary to expand its international market presence [1][2] - The total investment for setting up these subsidiaries is not expected to exceed 3 million USD [2] - The company aims to enhance its global operational network in the grinding systems and supporting equipment manufacturing business [2] Group 2 - The company is scheduled to disclose its 2025 annual report on April 27, 2026, which will include audited financial data [3] - The preliminary profit forecast indicates a significant decline in net profit, expected to drop by 45.05% to 60.03% year-on-year [3]
成都利君实业股份有限公司第六届董事会第十一次会议决议公告
Group 1 - The core point of the announcement is that Chengdu Lijun Industrial Co., Ltd. has approved the establishment of wholly-owned subsidiaries in Hong Kong and Peru through its wholly-owned subsidiary in Singapore, with a total investment not exceeding 3 million USD [6][12][15] Group 2 - The board meeting was held on February 5, 2026, with all 9 directors participating via remote voting, and the meeting complied with legal and regulatory requirements [2][3][5][4] - The investment aims to expand the company's international market for its main grinding systems and related equipment, enhancing its global operational network and market share [12][15] - The investment will be funded by the company's own funds and is not expected to significantly impact the company's financial status or ongoing operations [13][17]
2月5日晚间重要公告一览
Xi Niu Cai Jing· 2026-02-05 10:16
Group 1 - Company Jianhui Information plans to acquire 38% equity in Boke Guoxin for RMB 73.71 million, increasing its stake from 32% to 70%, making Boke Guoxin a subsidiary [1] - Company Guangshengtang's innovative drug GST-HG141 for hepatitis B has completed the enrollment of 578 participants in its Phase III clinical trial [2] - Company Hongjing Optoelectronics is establishing a partnership with a target scale of RMB 290 million, contributing RMB 3 million as a limited partner [3] Group 2 - Company Hongchang Technology intends to acquire 21% equity in Liangzhi Joint, which will make it the controlling shareholder with a 51% stake [4] - Company Xiexin Integrated has not yet received any orders in the "space photovoltaic" sector, which remains in the exploratory phase [5] - Company Xianheng International plans to reduce its shareholding by up to 3%, amounting to a maximum of 12.28 million shares [6] Group 3 - Company Furuijia plans to reduce its repurchased shares by up to 2%, totaling 18.93 million shares [7] - Company Tianqimo is planning to issue shares and pay cash to acquire assets, leading to a temporary suspension of its stock [8] - Company Shuangqiang Technology's director plans to reduce his holdings by up to 0.32% [9] Group 4 - Company Bairun plans to adjust the conversion price of its bonds due to stock prices falling below 85% of the conversion price [11] - Company Dongnan Network has won an EPC project worth RMB 994 million [12] - Company Anhui Energy has appointed Xu Wengong as the new general manager following the resignation of Fang Shiqing [13] Group 5 - Company Lijun plans to invest up to USD 3 million to establish subsidiaries in Hong Kong and Peru [14] - Company Zhenghe Ecology has signed a strategic cooperation agreement with the government of Beijing's Miyun District [15] - Company First Venture has elected Guo Chuan as the chairman of its board [16] Group 6 - Company Changxin Bochuang's shareholder has terminated an agreement to transfer 14.5 million shares [17] - Company Hengrui Medicine's HR091506 tablet application has been accepted by the National Medical Products Administration [18] - Company Hengrui Medicine's SHR-1894 injection has received approval for clinical trials [20] Group 7 - Company Longshen Rongfa has obtained a medical device production license [21] - Company Western Securities reported that its new borrowings exceeded 20% of its net assets [22] - Company Rongfa Nuclear Power's subsidiary has won a project worth RMB 101 million [23] Group 8 - Company Taiji Industry's subsidiary has a pre-bid for the Huahong FAB9B project with a bid amount of RMB 3.778 billion [24] - Company Suzhou High-tech plans to increase its investment in a subsidiary by RMB 780 million through a debt-to-equity swap [26] - Company Electric Power Investment's vice president has resigned due to work changes [27] Group 9 - Company Hengwei Technology reported a 30.13% increase in net profit for 2025 [28] - Company Fangsheng Pharmaceutical's subsidiary has received a drug production license [29] - Company Pilin Bio's subsidiary has received a notice for clinical trial acceptance for a hemostatic drug [31] Group 10 - Company Zhongxin Fluorine Material has received approval for a stock issuance to specific investors [32] - Company Shanhe Intelligent expects a total transaction amount with related parties to be RMB 1.197 billion in 2026 [33] - Company Warner Pharmaceutical's partner has completed Phase I clinical trials for a new drug [34]
利君股份(002651.SZ):新加坡全资子公司拟在香港和秘鲁设立下属子公司
Ge Long Hui A P P· 2026-02-05 09:18
格隆汇2月5日丨利君股份(002651.SZ)公布,为了拓展公司主营粉磨系统及其配套设备制造业务国际市 场,公司拟以自有资金通过新加坡全资子公司利君控股(新加坡)私人有限公司(简称"利君控股")在 香港投资设立2家全资二级子公司(简称"香港子公司"),拟通过上述新设立的香港子公司在秘鲁投资 设立1家全资三级子公司(简称"秘鲁子公司"),投资总额不超过300万美元。 ...
利君股份拟不超300万美元新设多家子公司
智通财经网· 2026-02-05 09:11
Core Viewpoint - The company plans to invest up to 3 million USD through its wholly-owned subsidiary in Singapore to establish two wholly-owned secondary subsidiaries in Hong Kong and subsequently a wholly-owned tertiary subsidiary in Peru, aiming to enhance its international market presence and operational efficiency [1] Group 1: Investment Strategy - The total investment amount for the new subsidiaries will not exceed 3 million USD [1] - The Hong Kong subsidiary will serve as the company's overseas investment management platform, coordinating overseas market strategies and investment layouts [1] - The Peru subsidiary is intended to meet sales and after-sales service needs in the region, allowing for quicker responses to customer demands [1] Group 2: Business Focus - The Singapore subsidiary, Lijun Holdings, is primarily responsible for the overseas sales of the company's main products in the cement building materials and metallurgical mining equipment sectors [1] - The establishment of these subsidiaries is part of the company's strategy to accelerate the expansion of its overseas market and enhance its global operational network [1]
利君股份:2月5日召开董事会会议
Mei Ri Jing Ji Xin Wen· 2026-02-05 09:10
Group 1 - The company, Lijun Co., announced that its 11th meeting of the 6th board of directors was held on February 5, 2026, via teleconference [1] - The meeting reviewed a proposal regarding the establishment of wholly-owned subsidiaries in Hong Kong and Peru by its wholly-owned subsidiary in Singapore [1]
利君股份(002651.SZ)拟不超300万美元新设多家子公司
智通财经网· 2026-02-05 09:08
公告称,利君控股为公司在新加坡设立的全资子公司,主要负责公司主营水泥建材、冶金矿山行业设备 及其配套产品的海外销售业务。公司将以利君控股为投资主体设立上述香港、秘鲁子公司,主要为加快 拓展相关行业的海外市场,构建全球运营网络,提升公司境外市场份额,推动公司国际化的发展战略。 香港子公司将作为公司海外投资管理平台,统筹推进海外市场战略和投资布局,提升海外业务运营效 率;秘鲁子公司主要为满足公司在秘鲁销售业务,提供售后配套服务需求,更快地响应客户需求。 智通财经APP讯,利君股份(002651.SZ)公告,公司拟以自有资金通过新加坡全资子公司利君控股(新加 坡)私人有限公司("利君控股")在香港投资设立2家全资二级子公司拟通过上述新设立的香港子公司在秘 鲁投资设立1家全资三级子公司,投资总额不超过300万美元。 ...
利君股份(002651) - 关于新加坡全资子公司在香港和秘鲁投资设立下属全资子公司的公告
2026-02-05 09:00
证券代码:002651 证券简称:利君股份 公告编号:2026-03 成都利君实业股份有限公司 关于新加坡全资子公司在香港和秘鲁 投资设立下属全资子公司的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整,没有虚假记载、误导性 陈述或重大遗漏。 一、对外投资概述 (一)根据成都利君实业股份有限公司(以下简称"公司")经营发展及战略规划, 为了拓展公司主营粉磨系统及其配套设备制造业务国际市场,公司拟以自有资金通过新 加坡全资子公司利君控股(新加坡)私人有限公司(以下简称"利君控股")在香港投 资设立 2 家全资二级子公司(以下简称"香港子公司"),拟通过上述新设立的香港子公 司在秘鲁投资设立 1 家全资三级子公司(以下简称"秘鲁子公司"),投资总额不超过 300 万美元。 (二)经公司 2026 年 2 月 5 日召开的第六届董事会第十一次会议审议通过了《关 于新加坡全资子公司在香港和秘鲁投资设立下属全资子公司的议案》,详细情况请参见 公司于 2026 年 2 月 6 日在《中国证券报》《上海证券报》《证券时报》及巨潮资讯网披 露的本公司公告。 根据相关法律法规及公司《章程》、《对外投资管理制度》的 ...
利君股份(002651) - 第六届董事会第11次会议决议公告
2026-02-05 09:00
证券代码:002651 证券简称:利君股份 公告编号:2026-02 成都利君实业股份有限公司 第六届董事会第十一次会议决议公告 3、本次董事会会议以通讯表决方式出席会议的董事 9 名,实际以通讯表决方式出 席会议的董事 9 名。 4、本次董事会会议的召集、召开符合法律法规和公司章程的规定。 二、董事会会议审议情况 本次会议以记名投票表决的方式形成了如下决议: 审议通过了《关于新加坡全资子公司在香港和秘鲁投资设立下属全资子公司的议 案》。 同意公司以自有资金通过新加坡全资子公司利君控股(新加坡)私人有限公司在香 港投资设立 2 家全资子公司,通过上述新设立的香港子公司共同出资在秘鲁投资设立 1 家全资子公司,投资总额不超过 300 万美元。 关于上述事项的具体情况,详见公司于 2026 年 2 月 6 日《中国证券报》《上海证券 报》《证券时报》及巨潮资讯网《关于新加坡全资子公司在香港和秘鲁投资设立下属全 资子公司的公告》。 本公司及董事会全体成员保证信息披露内容的真实、准确和完整,没有虚假记载、误导性 陈述或重大遗漏。 一、董事会会议召开情况 1、成都利君实业股份有限公司第六届董事会第十一次会议(以下简称" ...
利君股份:预计2025年净利润同比下降45.05%至60.03%
Jing Ji Guan Cha Wang· 2026-01-23 02:10
经济观察网2026年1月22日,利君股份(002651)发布2025年度业绩预告,预计2025年净利润4800万元 至6600万元,同比下降45.05%至60.03%;扣除非经常性损益后的净利润4100万元至5900万元,同比下 降49.61%至64.98%。 ...